Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2015-08-02 Director's Dealing
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Appendix 3X - Initial Director's Interest Notice 2 pages 53.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares held directly or indirectly, and interests in contracts. The content is focused on disclosure of personal shareholdings and interests of a company director. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or holdings by company directors and executives. The document length is short and specific to director interests, not a broader financial or management report.
2015-08-02 English
Primary sells Vision Eye Institute shares 1 page 96
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement regarding the sale of shares by Primary Health Care Ltd. It details the transaction of selling approximately 36 million shares in Vision Eye Institute Limited, including the financial impact and use of proceeds. The document is short (1107 characters) and focuses on a capital transaction rather than a full financial report or earnings release. It does not contain comprehensive financial statements or detailed financial performance data. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2015-07-30 English
PRY: Primary Health Care Sale to Jangho Group 1 pag
Major Shareholding Notification Classification · 95% confidence The document is a short announcement regarding a significant shareholding transaction: Primary Health Care Limited selling shares in Vision Eye Institute to Jangho Group, resulting in Jangho acquiring a 19.9% stake. It includes details of the share purchase price and the percentage stake acquired. There is no financial report, no detailed financial data, no management discussion, or other report content. The document is an announcement of a major shareholding change, which fits the category of Major Shareholding Notification (MRQ). The document length is short (1268 characters), consistent with a brief announcement rather than a full report.
2015-07-30 English
Change in substantial holding 29 pages 2.2MB
Regulatory Filings
2015-07-23 English
Primary Bonds Series A Update 2 pages 153.0KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Primary Bonds Series A Trust Section 283BF Quarterly Report' and references the Corporations Act 2001 (Cth) section 283BF, which relates to quarterly reporting requirements for bond issuances. It covers the quarter from 28 March 2015 to 27 June 2015 and includes detailed financial information about related body corporate receivables. The document is a quarterly report specifically for bondholders, containing substantive financial data and compliance information for the quarter. It is not an announcement of a report but the report itself. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 4233 characters, which is sufficient to contain substantive data, and it is not merely a certification or announcement. Hence, the classification is IR with high confidence. Q4 2015
2015-07-23 English
Change in substantial holding 7 pages 311.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and relevant interests of a substantial shareholder (T. Rowe Price Associates, Inc.) in Primary Health Care Limited. The form includes specifics about share purchases, voting power percentages, and associations. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes.
2015-07-16 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.